Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy

APEX Investigators, I. Stukena (Member of the Working Group)

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)
39 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science